secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2025-05-19T23:59:59+00:00
Accession:  0001437749-25-017616
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision Q1 revenue up 74% to $143K, net loss $4.0M; cash $450K
-------------------------------------------------------------------------

- Revenue $143K vs $82K YoY (+74%); net loss $4.0M including $1.2M non-cash charges.
- Cash $450K at March 31; after quarter end secured $1.5M private placement from institutional investors.
- Acquired Cardionomics assets via 82%-owned subsidiary Cardionomix, including CPNS system for ADHF.
- Acquired PeriKard, LLC (pericardial access kit); first U.S. patent allowed for LockeT device.
- Clinical data presented at HRS 2025: VIVO 94% accurate, LockeT safe/effective in 139-patient study.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925017616/0001437749-25-017616-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000143774925017616/vtak20250519_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-017616

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer